Morant Michael
Known title: General CounselCIK: 0001982006
Associated companies
Transaction History
| CHWY | ▼ Sell | Open Market | 189 | $6K | 8/2/2023 | View on chart |
| CHWY | ▲ Buy | Grant | 95,604 | $0 | 7/5/2023 | View on chart |
| CHWY | ▲ Buy | Grant | 10,885 | $0 | 6/26/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Chewy vet care growth offsets Mizuho price target cut
Chewy reported triple-digit growth in its vet care segment as clinic scale builds. Meanwhile, Mizuho maintained an Outperform rating but lowered its price target to $28. The stock currently trades near its 52-week low, reflecting mixed sentiment despite positive operational updates.
Chewy vet care growth offsets Mizuho price target cut. Chewy reported triple-digit growth in its vet care segment as clinic scale builds. Meanwhile, Mizuho maintained an Outperform rating but lowered its price target to $28. The stock currently trades near its 52-week low, reflecting mixed sentiment despite positive operational updates.